Vendor Intelligence Report: Tianjin Ruiwang New Material Technology Co

Published 3 Jul 2026. 27-page investigative report on who is behind Tianjin Ruiwang New Material Technology Co: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 154 Finnrick lab tests, Tianjin Ruiwang's overall pass rate is 68% (104 pass / 49 fail). The record is uneven rather than simply bad: GHK-Cu is the clearest relative strength, Retatrutide and Tirzepatide sit in a heavily tested but batch-dependent middle, and TB-500 is the sharpest avoid-or-test-first signal. The full report preserves the product-level results and methodology-divergence charts, including how ratings compress under stricter grading.

The OSINT trail shifts the buyer issue from existence to operating substance. UK filings show a real but dormant company controlled by a China-based sole director, with registered-office service addresses and a near-strike-off episode before the 2025 sales buildout. Archived web pages, B2B profiles, and one customs record point first to petroleum coke, asphalt, grease, carbon, and general industrial chemicals; the peptide-facing footprint appears later.

Channel risk is also concrete. The vendor has used two domains, multiple WhatsApp numbers, an archived About page with no address filled in, and an Instagram promotion claiming Shenzhen fulfillment. The report also documents COA evidence lacking batch numbers, meaning a certificate may prove only that some sample tested, not that the vial received matches it. Public accountability is thin: the field sweep found no organic Reddit or GLP-1 Forum discussion and no visible X/coupon affiliate ecosystem.

Inside the full report:

  • Complete per-product Finnrick pass/fail rates and methodology-divergence charts for all 8 products
  • Companies House filings for the UK shell, director/PSC control, dormant accounts, and strike-off event
  • Wayback, Bline, Made-in-China, and Eximpedia evidence for the industrial-materials baseline
  • Domain and channel map covering tjruiwang.com, tianjinruiwang.com, WhatsApp contacts, and the Shenzhen fulfillment claim
  • COA and batch-number traceability analysis, plus Reddit, GLP-1 Forum, X, and coupon-sweep results

Risk assessment

  • Product-specific quality risk — high: TB-500 (26.77%; 1 pass / 6 fail), BPC-157 (41.51%; 4 pass / 7 fail), and Tesamorelin (43.42%; 6 pass / 9 fail) are fail-heavy; stronger GHK-Cu does not generalize across the catalog.
  • Batch/COA traceability risk — high: Ascend/Janoshik and Instagram test materials were observed without usable batch numbers, preventing buyers from tying a COA to the vial received.
  • Manufacturer-verification risk — high: Public records show a dormant UK shell and petroleum/industrial-materials trading footprint, with no verified peptide manufacturing site or domestic Chinese registry record retrieved.
  • Channel-authenticity and fulfillment-opacity risk — medium: Two domains, multiple WhatsApp numbers, a blank archived address field, a Shenzhen shipping claim, and no official-channel or anti-counterfeit list weaken buyer verification.
  • Community-accountability risk — medium: Despite substantial Finnrick testing volume, Reddit/GLP-1 Forum and X/coupon sweeps found no organic public buyer discussion or referral footprint.